134.31
price up icon8.33%   10.33
after-market Dopo l'orario di chiusura: 134.31
loading
Precedente Chiudi:
$123.98
Aprire:
$127.53
Volume 24 ore:
1.05M
Relative Volume:
1.83
Capitalizzazione di mercato:
$8.81B
Reddito:
$3.55B
Utile/perdita netta:
$370.24M
Rapporto P/E:
24.51
EPS:
5.48
Flusso di cassa netto:
$355.96M
1 W Prestazione:
+7.49%
1M Prestazione:
+11.41%
6M Prestazione:
-3.05%
1 anno Prestazione:
-14.15%
Intervallo 1D:
Value
$127.53
$135.99
Intervallo di 1 settimana:
Value
$121.96
$135.99
Portata 52W:
Value
$103.23
$164.28

Aptargroup Inc Stock (ATR) Company Profile

Name
Nome
Aptargroup Inc
Name
Telefono
(815) 477-0424
Name
Indirizzo
265 EXCHANGE DRIVE, CRYSTAL LAKE, IL
Name
Dipendente
13,500
Name
Cinguettio
@aptar
Name
Prossima data di guadagno
2024-10-24
Name
Ultimi documenti SEC
Name
ATR's Discussions on Twitter

Compare ATR vs ISRG, BDX, RMD, MDLN, ALC

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Instruments & Supplies icon
ATR
Aptargroup Inc
134.31 8.14B 3.55B 370.24M 355.96M 5.48
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
488.15 169.16B 10.06B 2.88B 2.49B 7.876
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
210.02 58.84B 21.84B 1.68B 2.67B 5.8293
Medical Instruments & Supplies icon
RMD
Resmed Inc
271.63 38.90B 5.40B 1.49B 1.78B 10.12
Medical Instruments & Supplies icon
MDLN
Medline Inc
47.30 38.45B 27.43B 1.27B 1.01B 1.5829
Medical Instruments & Supplies icon
ALC
Alcon Inc
78.83 38.50B 10.19B 1.05B 1.38B 2.1044

Aptargroup Inc Stock (ATR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2026-01-06 Downgrade Wells Fargo Overweight → Equal Weight
2025-11-03 Downgrade William Blair Outperform → Mkt Perform
2025-09-04 Iniziato KeyBanc Capital Markets Overweight
2025-01-07 Iniziato Raymond James Outperform
2025-01-06 Downgrade BofA Securities Buy → Neutral
2024-10-14 Aggiornamento Jefferies Hold → Buy
2024-04-29 Aggiornamento William Blair Mkt Perform → Outperform
2024-01-03 Aggiornamento Robert W. Baird Neutral → Outperform
2021-08-02 Downgrade William Blair Outperform → Mkt Perform
2021-04-14 Downgrade Robert W. Baird Outperform → Neutral
2020-10-14 Iniziato Seaport Global Securities Neutral
2020-04-27 Aggiornamento BofA/Merrill Neutral → Buy
2020-03-25 Aggiornamento BMO Capital Markets Market Perform → Outperform
2020-03-04 Aggiornamento Wells Fargo Equal Weight → Overweight
2020-02-26 Downgrade Morgan Stanley Overweight → Equal-Weight
2019-07-08 Iniziato Morgan Stanley Overweight
2019-04-05 Reiterato BofA/Merrill Underperform
2019-02-27 Aggiornamento Robert W. Baird Neutral → Outperform
2018-05-18 Iniziato Jefferies Hold
2016-12-07 Downgrade BofA/Merrill Buy → Underperform
2016-10-13 Iniziato Jefferies Hold
2016-01-05 Downgrade Robert W. Baird Outperform → Neutral
2015-11-02 Aggiornamento Deutsche Bank Hold → Buy
2015-09-15 Aggiornamento BofA/Merrill Neutral → Buy
2015-05-01 Aggiornamento BofA/Merrill Underperform → Neutral
2013-02-19 Reiterato Deutsche Bank Hold
2013-01-08 Aggiornamento Robert W. Baird Neutral → Outperform
2012-07-10 Downgrade KeyBanc Capital Mkts Buy → Hold
2012-04-11 Iniziato KeyBanc Capital Mkts Buy
2011-06-13 Aggiornamento KeyBanc Capital Mkts Hold → Buy
Mostra tutto

Aptargroup Inc Borsa (ATR) Ultime notizie

pulisher
06:14 AM

AptarGroup (ATR) Reports Strong Q4 Sales Growth Amid Margin Pres - GuruFocus

06:14 AM
pulisher
05:33 AM

AptarGroup Q4 Earnings Call Highlights - Yahoo Finance

05:33 AM
pulisher
04:32 AM

AptarGroup Inc (ATR) Q4 2025 Earnings Call Highlights: Strong Re - GuruFocus

04:32 AM
pulisher
12:05 PM

APTARGROUP, INC. SEC 10-K Report - TradingView

12:05 PM
pulisher
10:55 AM

AptarGroup Q4 2025 slides: Sales surge 14% while margins face pressure - Investing.com

10:55 AM
pulisher
10:52 AM

Earnings call transcript: AptarGroup Q4 2025 earnings beat expectations, stock surges - Investing.com India

10:52 AM
pulisher
10:25 AM

AptarGroup declares $0.48 dividend - MSN

10:25 AM
pulisher
Feb 05, 2026

How Strong Q4 Results and FX-Tied Guidance Will Impact AptarGroup (ATR) Investors - simplywall.st

Feb 05, 2026
pulisher
Feb 05, 2026

Aptar Reports Fourth Quarter and Annual 2025 Results - Aptar

Feb 05, 2026
pulisher
Feb 05, 2026

AptarGroup (ATR) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance

Feb 05, 2026
pulisher
Feb 05, 2026

Aptar (ATR) Projects Growth and Strategic Investments for the Fu - GuruFocus

Feb 05, 2026
pulisher
Feb 05, 2026

AptarGroup (ATR) Reports Strong Q4 Revenue Boosted by Segment Gr - GuruFocus

Feb 05, 2026
pulisher
Feb 05, 2026

AptarGroup Inc (NYSE:ATR) Beats Q4 Revenue Estimates, Issues Cautious Q1 Outlook - Chartmill

Feb 05, 2026
pulisher
Feb 05, 2026

AptarGroup (ATR) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance

Feb 05, 2026
pulisher
Feb 05, 2026

AptarGroup: Fourth Quarter Earnings Overview - Bitget

Feb 05, 2026
pulisher
Feb 05, 2026

AptarGroup Q4 Non-GAAP Earnings Fall, Revenue Rises; Shares Advance After Hours - marketscreener.com

Feb 05, 2026
pulisher
Feb 05, 2026

AptarGroup: Q4 Earnings Snapshot - kens5.com

Feb 05, 2026
pulisher
Feb 05, 2026

AptarGroup Inc. Reveals Drop In Q4 Income - Nasdaq

Feb 05, 2026
pulisher
Feb 05, 2026

AptarGroup (ATR) Releases Q4 2025 Earnings: Revenue Growth but EPS Miss - Quiver Quantitative

Feb 05, 2026
pulisher
Feb 05, 2026

(ATR) AptarGroup, Inc. Expects Q1 Adjusted EPS Range $1.13$1.21 - marketscreener.com

Feb 05, 2026
pulisher
Feb 05, 2026

AptarGroup, Inc. Reports Fourth Quarter and Annual 2025 Results - TradingView

Feb 05, 2026
pulisher
Feb 02, 2026

Cash Dividend On The Way From AptarGroup (ATR) - Nasdaq

Feb 02, 2026
pulisher
Feb 02, 2026

AptarGroup, Inc. (ATR) Stock Analysis: Exploring The 27% Upside Potential For Investors - DirectorsTalk Interviews

Feb 02, 2026
pulisher
Jan 31, 2026

Winners Losers: What is the dividend yield of AptarGroup IncPortfolio Profit Report & Safe Entry Point Alerts - baoquankhu1.vn

Jan 31, 2026
pulisher
Jan 30, 2026

Trading Recap: Is AptarGroup Inc part of any major index2025 Performance Recap & Fast Moving Market Watchlists - baoquankhu1.vn

Jan 30, 2026
pulisher
Jan 29, 2026

Earnings Preview: AptarGroup (ATR) Q4 Earnings Expected to Decline - Finviz

Jan 29, 2026
pulisher
Jan 28, 2026

Is AptarGroup Inc.’s growth already priced inGlobal Markets & Intraday High Probability Alerts - Mfd.ru

Jan 28, 2026
pulisher
Jan 27, 2026

City Council OKs AptarGroup tax abatements, delays Rankinen request - Midland Daily News

Jan 27, 2026
pulisher
Jan 23, 2026

AptarGroup declares $0.48 quarterly dividend, sets annual meeting By Investing.com - Investing.com Australia

Jan 23, 2026
pulisher
Jan 22, 2026

AptarGroup Keeps Quarterly Dividend at $0.48 a Share, Payable Feb. 25 to Shareholders of Record on Feb. 4 - marketscreener.com

Jan 22, 2026
pulisher
Jan 22, 2026

AptarGroup declares $0.48 quarterly dividend, sets annual meeting - Investing.com

Jan 22, 2026
pulisher
Jan 22, 2026

Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details - Aptar

Jan 22, 2026
pulisher
Jan 21, 2026

Aptar Again Recognized with Prestigious 'A' Score on the CDP Cli - GuruFocus

Jan 21, 2026
pulisher
Jan 21, 2026

Aptar Again Recognized with Prestigious ‘A’ Score on the CDP Climate Change Assessment - marketscreener.com

Jan 21, 2026
pulisher
Jan 15, 2026

Surprises Report: Is AptarGroup Inc.’s growth already priced inWeekly Trading Summary & Low Drawdown Trading Strategies - baoquankhu1.vn

Jan 15, 2026
pulisher
Jan 15, 2026

Fund Flows: Is AptarGroup Inc stock undervalued right now2025 Growth vs Value & Entry Point Confirmation Alerts - baoquankhu1.vn

Jan 15, 2026
pulisher
Jan 15, 2026

Is the Options Market Predicting a Spike in AptarGroup Stock? - Nasdaq

Jan 15, 2026
pulisher
Jan 14, 2026

Aptar's Nasal Vaccine Delivery Solutions Featured in CastleVax Phase II Clinical Trial of an Intranasal COVID-19 Vaccine Candidate - marketscreener.com

Jan 14, 2026
pulisher
Jan 14, 2026

Aptar’s nasal delivery solutions used in CastleVax COVID-19 vaccine trial - Investing.com Nigeria

Jan 14, 2026
pulisher
Jan 14, 2026

Aptar’s nasal delivery solutions used in CastleVax COVID-19 vaccine trial By Investing.com - Investing.com South Africa

Jan 14, 2026
pulisher
Jan 13, 2026

Aptar’s Nasal Vaccine Delivery Solutions Featured in CastleVax Phase II Clinical Trial of an Intranasal COVID-19 Vaccine Candidate - Aptar

Jan 13, 2026
pulisher
Jan 13, 2026

Nasal COVID-19 vaccine trial uses Aptar devices to test immunity levels - Stock Titan

Jan 13, 2026
pulisher
Jan 13, 2026

Aptar's Eye Care Solutions Designed to Improve Dosing Precision, Including Newest Technology, Beat the Blink - marketscreener.com

Jan 13, 2026
pulisher
Jan 13, 2026

AptarGroup Unveils Innovative Eye Drop Delivery System in Strategic Partnership - AD HOC NEWS

Jan 13, 2026

Aptargroup Inc Azioni (ATR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$187.60
price up icon 6.82%
$78.12
price up icon 1.48%
medical_instruments_supplies COO
$82.10
price up icon 2.50%
$74.81
price up icon 0.15%
medical_instruments_supplies WST
$248.95
price up icon 7.48%
medical_instruments_supplies ALC
$78.83
price up icon 0.59%
Capitalizzazione:     |  Volume (24 ore):